Last edition
News about "cancer therapies "
NAYA Therapeutics, a US-based clinical-stage biopharmaceutical company developing next-generation cancer therapies, has entered into a research and manufacturing partnership with China’s Alpha Nuclide, a radiopharmaceutical solutions company leading global efforts in Astatine-211 (211At) supply and CDMO services.
Cancer Therapies | 17/10/2025 | By Dineshwori
FDA Grants BTD to Raludotatug Deruxtecan for Platinum-Resistant Ovarian Cancer
This is the first BTD granted for Raludotatug Deruxtecan, the second for the Daiichi Sankyo-Merck partnership and the 15th across Daiichi Sankyo’s oncology portfolio, marking a significant milestone in the companies’ joint efforts to develop innovative cancer therapies.
Cancer Therapies | 16/09/2025 | By Dineshwori
Johnson and Johnson Commits USD 2 Billion to Expand US Manufacturing Amid Tariff Pressures
Johnson and Johnson has announced it will invest USD 2 billion in expanding its US manufacturing capacity over the next decade, responding to escalating concerns over trade and potential drug import tariffs.
Cancer Therapies | 22/08/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy